Value Creation Consulting
Home
About Me
News
Pivotal Blog
Contact Me
More
Turnover - Is it Always Bad?
Join our mailing list
Never miss a blog or an update!
Leadership - Supporting Through Failure
Are Large CROs Still Buying Mid-Size CROs?
Have CROs Been Great Investments?
Clinical Trial Ancillary Supplies & Equipment are Difference Makers!
2021 - Clinical Research Bounces Back
Biotech - Don't Call It a Comeback
COVID-19 - Clinical Trial Impact
COVID-19 - Assessing the Data
CRO Account Directors Make A Big Impact
Mid-Size CRO Competitive Landscape
Recent Biotech IPO Analysis
Biotech FDA Approvals Peak
CRO Utilization - Part #2
CRO Utilization Part #1
Biotech's Impact on Drug Development
Effective Communication – The Overlooked CRO Advantage
Where CRO Size Doesn't Matter - Glassdoor.com
Project Leaders: The Unsung CRO Heroes
CRO: Does Size Matter?
Contractors vs. Employees: When CROs Outsource
Quick Impact - PRA Acquires Symphony Health
Parexel Backlog Adjustments & Burn Rates
Simple Metrics Clinical Research Organizations Should Utilize - But Don't
Pediatric Clinical Trials - The Niche That Shouldn't Be a Niche
Top Missteps Made By Owners When Selling Their Business
Hooray - It's Budget Season - Not!
Patient Recruitment: Clinical Research's "White Whale"?
CRO Consolidations - Does 1 + 1 = 3?
Improving CRO Gross Margins with Project Margins
What Can a CRO do to Deal with the Cancellation Bugaboo?
Buying or Selling a CRO? Better Check the Backlog
The Impact of R&D and Medical Device Trends on Small to Mid-Size CROs
Why CRO Win Rates Matter
Will More Large CROs be Acquired?
Have Small and Mid-Size CRO’s Overachieved?
